Ranok is a privately held, pre-clinical stage biopharmaceutical company that is pioneering an innovative targeted protein degradation technology for the discovery and development of novel therapeutics. Ranok was founded by a leadership team of industry veterans from both Chinese and American biotech and pharmaceutical companies and is based in two of the world’s leading centers of innovation and medical research: Hangzhou, China and Boston, Massachusetts USA. By bringing together the cutting edges of medical research from both China and the United States, our goal is to create transformative medicines for patients suffering from cancer and other serious diseases.

 

For more information, please follow us at LinkedIn and Twitter @RanokTx.

 

 

Media & Investor Contact:

Ms. Xiaoyan Qiu

Ranok Therapeutics

bd@ranoktherapeutics.com

About